Journal: Neurotherapeutics
Article Title: LINE-1 hypomethylation in cell-free DNA of high-grade glioma patients correlates with tissue levels and is associated with reduced DNMT1 and H4K20me3 expression
doi: 10.1016/j.neurot.2025.e00754
Figure Lengend Snippet: A Immunohistochemical expression of DNMT1, H4K20me3, H3K9me3 in normal brain tissues, grade 2 and grade 4 astrocytomas, respectively. Normal brain tissue displays lower DNMT1, H4K20me3 and H3K9me3 immunostaining than in astrocytic tumors. Within tumors, DNMT1, H4K20me3 and H3K9me3 immunostaining was reduced from grade 2 to grade 4. B DNMT1, H4K20me3, H3K9me3 H -score in normal brain and astrocytomas tissues in respect to histological grade. DNMT1, H4K20me3 and H3K9me3 expressions were significantly elevated in grade 2 in comparison to grade 4 astrocytomas. C Detection and quantification of DNMT1, H4K20me3 and H3K9me3 expression in grade 2 and 4 astrocytomas as well as normal brain tissues. All experiments were repeated at least three times and statistical analysis of the protein levels from three experiments (normalized to actin levels) is shown. ∗ p < 0.05, ∗∗∗ p < 0.001.
Article Snippet: Incubation of all the sections was performed overnight with monoclonal primary DNMT1 antibody (sc-271729, Santa Cruz Biotechnology, Dallas, USA, 1:100) or H4K20me3 (Ab 78517, Abcam, Cambridge, UK, 1:300) or H3K9me3 (CMA 308, Merck Millipore, MA, USA, 1:100).
Techniques: Immunohistochemical staining, Expressing, Immunostaining, Comparison